About
Technology
Issues
FAQ
Links
Official Page
Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.